Trokendi XR
topiramate · Capsule, Extended Release · Oral
No FDA structured label text is available for Trokendi XR. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Topiramate in 4 products
Trokendi XR NDC products (4)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 17772-101 | Topiramate 25 mg/1 Capsule, Extended Release | Supernus Pharmaceuticals, Inc. | NDA |
| 17772-102 | Topiramate 50 mg/1 Capsule, Extended Release | Supernus Pharmaceuticals, Inc. | NDA |
| 17772-103 | Topiramate 100 mg/1 Capsule, Extended Release | Supernus Pharmaceuticals, Inc. | NDA |
| 17772-104 | Topiramate 200 mg/1 Capsule, Extended Release | Supernus Pharmaceuticals, Inc. | NDA |
Frequently asked questions
Who makes Trokendi XR?
Trokendi XR is listed by 1 labeler in the FDA NDC directory, including Supernus Pharmaceuticals, Inc..